Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor

In the original publication of this article, the license subtype should be CC BY and not CC BY-NC.

Bibliographische Detailangaben

Veröffentlicht in:	Investigational new drugs 2019-06, Vol.37 (3), p.591-591
Hauptverfasser:	Ito, Tetsuhide, Okusaka, Takuji, Nishida, Toshirou, Yamao, Kenji, Igarashi, Hisato, Morizane, Chigusa, Kondo, Shunsuke, Mizuno, Nobumasa, Hara, Kazuo, Sawaki, Akira, Hashigaki, Satoshi, Kimura, Nobuyuki, Murakami, Mami, Ohki, Emiko, Chao, Richard C., Imamura, Masayuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Correction Medicine Medicine & Public Health Metastases Neuroendocrine tumors Oncology Pancreas Pharmacology/Toxicology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!